Related Experiment Video
Updated: Jun 17, 2026
07:09
Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
Published on: January 7, 2019
HVEM/LIGHT/BTLA/CD160 cosignaling pathways as targets for immune regulation
M L del Rio1, C L Lucas, L Buhler
1Laboratory of Immunobiology, Institute of Biomedicine, 24071-Leon, Spain.
Journal of Leukocyte Biology
|December 17, 2009
Summary
Targeting specific immune pathways offers a safer alternative to broad immunosuppression for transplant rejection and autoimmune diseases. Modulating the HVEM/LIGHT/BTLA/CD160 pathway could control harmful immune responses while preserving essential immunity.
Area of Science:
- Immunology
- Transplantation
- Autoimmune Diseases
Background:
- Global immunosuppression is standard for transplant rejection and autoimmune diseases but carries risks of infection and organ toxicity.
- There is a critical need for targeted immunotherapies that inhibit detrimental immune responses while maintaining protective immunity.
Purpose of the Study:
- To explore the potential of targeting the HVEM/LIGHT/BTLA/CD160 pathway for immune modulation.
- To discuss strategies for controlling adverse immune responses by manipulating this costimulatory/coinhibitory pathway.
Main Methods:
- Review of research on receptor/ligand interactions between dendritic cells (DCs) and T cells.
- Analysis of the HVEM/LIGHT/BTLA/CD160 pathway as a therapeutic target.
Main Results:
- The HVEM/LIGHT/BTLA/CD160 pathway represents a promising target for immune intervention.
- Blockade of HVEM/LIGHT or activation of BTLA/CD160 signaling may offer controlled inhibition of harmful immune responses.
Conclusions:
- Targeting the HVEM/LIGHT/BTLA/CD160 pathway presents a novel strategy for managing immune-related conditions.
- This approach could lead to more precise immune therapies with reduced side effects compared to global immunosuppression.
More Related Videos
Related Concept Videos
02:26NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
01:22T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
01:24B Cell Activation and Differentiation
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
02:26NF-kB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...